eBioMedicine

SJR Rank #483H-index: 156SJR: 3.742Best quartile: Q1Open AccessAPC: US$5,780Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Elsevier B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.951.92.853.8

Subject Categories

  • Biochemistry, Genetics and Molecular Biology (miscellaneous)Q1
  • Medicine (miscellaneous)Q1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

SARS-CoV-2 and COVID-19 ResearchGut microbiota and healthCOVID-19 Clinical Research StudiesHIV Research and TreatmentEpigenetics and DNA MethylationCancer Immunotherapy and BiomarkersGenetic Associations and EpidemiologyImmune Cell Function and Interactionvaccines and immunoinformatics approachesFerroptosis and cancer prognosis

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs045090013501800

Documents per Year

202220250200400600800

Detailed Information

ISSN

2352-3964

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

10.22

References per Document

52.42

Coverage

2014-2026

Scope

The journal is dedicated to publishing original research that elucidates, or aims to modify, disease pathways and mechanisms–with the goal of advancing our knowledge in any biomedical discipline with relevance to human health. Together with EClinicalMedicine, EBioMedicine is part of The Lancet’s open access offering for quality biomedical research.

Metrics from SCImago Journal Rank 2025. View on SCImago